AI Poised to Revolutionise a Key Test for Genetic Damage

Detecting subtle signs of DNA damage in our cells is vital for public health, but the current method is a bottleneck. Scientists manually count cellular markers called micronuclei, an indicator of genetic damage. This process is slow, laborious, and suffers from inconsistencies between observers, limiting the reliability of large studies.

A minimally invasive cheek swab test, the Buccal Micronucleus Cytome (BMCyt) assay, is valuable for monitoring populations exposed to environmental hazards, but its potential is held back by these analytical challenges.

Now, researchers highlight the untapped potential of integrating AI into the assay. Deep learning algorithms have already revolutionised other lab analyses and can automatically detect micronuclei with high precision. This AI-powered approach promises to eliminate observer bias, increase sample throughput, and improve reproducibility. By making the analysis more robust and scalable, AI could transform the BMCyt assay into a more powerful tool for large-scale epidemiological studies and human biomonitoring.